Quantcast
Last updated on April 17, 2014 at 14:35 EDT

Latest Prostate cancer screening Stories

2012-09-11 10:24:44

BETHESDA, Md., Sept. 11, 2012 /PRNewswire-USNewswire/ -- September is National Prostate Cancer Awareness Month. Prostate cancer is the second most commonly diagnosed type of cancer among American men. For reasons that are still unknown, African American men are more likely to get prostate cancer than men from other racial/ethnic groups. They are also twice as likely to die from prostate cancer as other men. (Logo: http://photos.prnewswire.com/prnh/20111018/DC89117LOGO) You may have heard...

2012-09-04 06:27:39

Prostate Conditions Education Council Applauds FDA Priority Review and Approval DENVER, Sept. 4, 2012 /PRNewswire-USNewswire/ -- Leading prostate cancer group, the Prostate Conditions Education Council (PCEC), applauds today's approval by the United States Food and Drug Administration (FDA) of a groundbreaking new therapy, Xtandi, formerly known as MDV3100. The drug has shown promise in clinical trials, extending the life of men with advanced prostate cancer even following other...

2012-08-24 00:19:47

Survival rate for African-American men now comparable to Caucasians, the Journal of Urology reports The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease. A new study published in The Journal of Urology® reports that in the "PSA era," survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the...

Prostate Cancer Patients More Likely To Die From Other Conditions Than The Cancer Itself
2012-07-27 12:47:13

Connie K. Ho for redOrbit.com — Your Universe Online A new study from the Harvard School of Public Health (HSPH) found that men who are diagnosed with prostate cancer have a greater chance to die due to preventable conditions like heart disease, rather than from the cancer itself. The study, the largest done to date, examines the causes of death related to men who have prostate cancer. The researchers believe that the findings show the importance of maintaining a healthy...

2012-06-21 02:26:35

Key Legislators, Physicians, & Advocates Create a Massachusetts Model of National Leadership in Recognizing Prostate Cancer as a Priority in Public Health and Patient Care Disparities BOSTON, June 21, 2012 /PRNewswire-USNewswire/ -- Massachusetts State Senate President Therese Murray, Speaker of the House Robert DeLeo and more than two dozen political and medical leaders will participate in the Prostate Cancer Awareness Day on June 28 from 10:00 a.m. - 2:00 p.m. at the State House...

2012-05-07 19:53:55

Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal). The United States Preventive Services Task Force, which last issued prostate screening guidelines in 2008, recently issued a draft recommendation against prostate-specific antigen (PSA) screening for men of all ages. However, the American Cancer Society and the American...

2012-05-01 09:36:24

A new analysis suggests the benefits of mammography screening every other year outweigh the potential harms for women aged 40 to 49 who are at an increased risk of developing breast cancer -- a finding that could affect one out of every five American women. The researchers also found greater harms from screening done with digital mammography compared to film mammography. These findings, with contributions from three national research groups, are published in the May 1 issue of Annals of...

2012-04-30 05:26:42

Despite recommendations in 2008 from the United States Preventive Services Task Force against testing for prostate cancer in men aged 75 years or older, almost half of men in that age group continue to get screening tests. In 2005, before the recommendations were released, 43 percent of men age 75 and above elected to take the prostate-specific antigen (PSA) test. In August 2008, the Task Force stated it "recommends against the service," arguing "there is moderate or high certainty the...

2012-04-03 05:32:42

(Ivanhoe Newswire) -- A new study shows that men with prostate cancer may be able to reduce the growth rate of cancer with the help of a commonly prescribed diabetes medication known as metformin. Although metformin is most commonly prescribed to treat diabetes, previous studies have shown that it is capable of slowing down cancerous cells in patients with prostate cancer. Anthony M. Joshua and colleagues, of Princess Margaret Hospital, University Health Network in Toronto, Ontario,...

2012-03-16 05:44:37

(Ivanhoe Newswire)-- Prostate cancer is the most common cause of death from cancer in men over age 75. An 11 year study looked at death in men whom prostate cancer was diagnosed pre death and post death. The study consisted of 182,160 men between the ages of 50 and 74 years at the start of the study, with a predefined core age group of 162,388 men 55 to 69 years of age. The trial was conducted in eight European countries. Men who were randomly assigned to the screening group were...